Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.41 |
| ▸ | CHRM3 known ✓ | P20309 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 4/20 | 0.42 |
| ▸ | APAF1 | O14727 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.42 |
| ▸ | MC4R | P32245 | 2/20 | 0.42 |
| ▸ | UBE2N | P61088 | 2/20 | 0.42 |
| ▸ | RAD52 | P43351 | 2/20 | 0.42 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.41 |
| ▸ | LMNA | P02545 | 5/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12604824 | 0.82 | MEN1 (0.53) | MEN1KMT2AALDH1A1USP2APAF1 | |
| Bromide SCHEMBL1774760 | 0.81 | MEN1 (0.54) | MEN1KMT2AALDH1A1USP2APAF1 | |
| Bromide SCHEMBL1775522 | 0.81 | MEN1 (0.54) | MEN1KMT2AALDH1A1USP2APAF1 | |
| Iodide SCHEMBL1775657 | 0.78 | ALDH1A1 (0.68) | MEN1KMT2AALDH1A1USP2APAF1 | |
| SCHEMBL3939116 | 0.76 | ALDH1A1 (0.65) | MEN1KMT2AALDH1A1USP2APAF1 | |
| SCHEMBL12604822 | 0.76 | MEN1 (0.57) | MEN1KMT2AALDH1A1USP2APAF1 | |
| Bromide SCHEMBL1774748 | 0.75 | MEN1 (0.59) | MEN1KMT2AALDH1A1USP2APAF1 | |
| Bromide SCHEMBL1774747 | 0.75 | MEN1 (0.59) | MEN1KMT2AALDH1A1USP2APAF1 | |
| SCHEMBL8185372 | 0.74 | SIGMAR1 (0.50) | MEN1KMT2AALDH1A1USP2APAF1 | |
| Iodide SCHEMBL1774916 | 0.73 | MEN1 (0.58) | MEN1KMT2AALDH1A1USP2APAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943606-B2 | Compositions and methods to control abnormal cell growth | CANCURE LABORATORIES, LLC (US) | 2011-05-17 | — | — | US | disclosed |
| US-7781423-B2 | Compounds to promote regeneration of bone marrow | CANCURE LABORATORIES, LLC (US) | 2010-08-24 | — | — | US | disclosed |
| US-20100048668-A1 | COMPOSITIONS AND METHODS TO CONTROL ABNORMAL CELL GROWTH | CANCURE LABORATORIES, LLC (US) | 2010-02-25 | — | — | US | disclosed |
| US-20100022617-A1 | COMPOSITIONS AND METHODS TO CONTROL ABNORMAL CELL GROWTH | CANCURE LABORATORIES, LLC (US) | 2010-01-28 | — | — | US | disclosed |
| US-7589083-B2 | [3-(3,4-Dimethyl-9-oxo-9H- thioxanthen-2-yloxy)-2- hydroxypropyl]trimethyl- ammonium chloride; antitumor; simultaneously enhancing the efficacy and decreasing the toxicity of chemotherapy by single agents | CANCURE LABORATORIES, LLC (US) | 2009-09-15 | — | — | US | disclosed |
| US-20090004136-A1 | COMPOUNDS TO PROMOTE REGENERATION OF BONE MARROW | ZOLTAN LABORATORIES LLC (US) | 2009-01-01 | — | — | US | disclosed |
| US-20080234234-A1 | COMPOUNDS TO PROMOTE REGENERATION OF BONE MARROW | ZOLTAN LABORATORIES, LLC (US) | 2008-09-25 | — | — | US | disclosed |
| US-7423029-B1 | from endogenous or exogenous stem/progenitor cells and to normalize blood cell and platelet counts; e.g. [3-(3,4-dimethyl-9-oxo-9H-thioxanthen-2-yloxy)-2-hydroxypropyl]trimethylammonium chloride; antitumor and AIDS agent; low toxicity, side effect reduction | ZOLTAN LABORATORIES, LLC (US) | 2008-09-09 | — | — | US | disclosed |
| EP-1931332-A2 | COMPOUNDS AND COMPOSITIONS TO CONTROL ABNORMAL CELL GROWTH | ZOLTAN LABORATORIES LLC (US) | 2008-06-18 | — | — | EP | disclosed |
| WO-2007032818-A2 | COMPOUNDS AND COMPOSITIONS TO CONTROL ABNORMAL CELL GROWTH | ZOLTAN LABORATORIES LLC (US) | 2007-03-22 | — | — | WO | disclosed |
| US-20070060634-A1 | COMPOUNDS AND COMPOSITIONS TO CONTROL ABNORMAL CELL GROWTH | ZOLTAN LABORATORIES LLC (US) | 2007-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090004136-A1 | COMPOUNDS TO PROMOTE REGENERATION OF BONE MARROW | PDGFA, BMP4, BMP2 | CHRM1 4598/4885CHRM3 3892/4885MEN1 3017/4885 |
| US-20070060634-A1 | COMPOUNDS AND COMPOSITIONS TO CONTROL ABNORMAL CELL GROWTH | ALPP, DNTT, ALPG | CHRM1 4779/4885CHRM3 4395/4885MEN1 3192/4885 |
| US-20100048668-A1 | COMPOSITIONS AND METHODS TO CONTROL ABNORMAL CELL GROWTH | ALPP, ALPG, MKI67 | CHRM1 4720/4885CHRM3 4519/4885MEN1 2734/4885 |
| US-20080234234-A1 | COMPOUNDS TO PROMOTE REGENERATION OF BONE MARROW | PDGFA, BMP4, BMP2 | CHRM1 4598/4885CHRM3 3892/4885MEN1 3017/4885 |
| US-20100022617-A1 | COMPOSITIONS AND METHODS TO CONTROL ABNORMAL CELL GROWTH | ALPP, ALPG, DNTT | CHRM1 4758/4885CHRM3 4283/4885MEN1 3329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.